Published in Heart Fail Rev on April 01, 2003
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet (1999) 11.26
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med (1995) 5.22
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation (1983) 3.99
The hibernating myocardium. Am Heart J (1989) 3.61
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med (1986) 2.63
Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol (1986) 2.20
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol (1992) 2.18
A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation (1985) 1.93
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation (1999) 1.80
Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation (1989) 1.75
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol (1997) 1.68
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol (1999) 1.60
Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation (1997) 1.55
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol (1998) 1.45
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation (1994) 1.21
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol (1999) 1.19
Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol (1998) 1.15
Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol (1998) 1.15
Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol (1985) 1.15
Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation (1999) 1.14
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (1999) 1.13
Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg (1998) 1.11
Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation (1988) 1.04
Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg (1993) 1.01
Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol (1996) 0.97
Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol (1997) 0.95
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J Thorac Cardiovasc Surg (1998) 0.95
Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol (1998) 0.95
Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg (1994) 0.95
Coronary artery bypass grafting in patients with ejection fractions below forty percent. Early and late results in 466 patients. J Thorac Cardiovasc Surg (1983) 0.93
Results of revascularization in patients with severe left ventricular dysfunction. Circulation (1995) 0.87
Coronary revascularisation for postischaemic heart failure: how myocardial viability affects survival. Heart (1999) 0.86
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation (1991) 0.85
Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg (1993) 0.83
Hibernating myocardium. Am Heart J (1989) 0.80
Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. J Thorac Cardiovasc Surg (2012) 3.74
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol (2006) 3.31
The frozen elephant trunk for the treatment of chronic dissection of the thoracic aorta: a multicenter experience. Ann Thorac Surg (2011) 2.51
Reply to the editor. J Thorac Cardiovasc Surg (2013) 1.97
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol (2006) 1.65
Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg (2012) 1.62
Clinical registries: governance, management, analysis and applications. Eur J Cardiothorac Surg (2013) 1.58
Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Eur J Cardiothorac Surg (2008) 1.57
The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg (2013) 1.55
Contemporary outcomes of urgent coronary artery bypass graft surgery following non-ST elevation myocardial infarction: urgent coronary artery bypass graft surgery consistently outperforms Global Registry of Acute Coronary Events predicted survival. Eur J Cardiothorac Surg (2012) 1.50
The European Association for Cardio-Thoracic Surgery (EACTS) database: an introduction. Eur J Cardiothorac Surg (2013) 1.42
Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg (2006) 1.36
Patient-prosthesis mismatch does not affect survival following aortic valve replacement. Eur J Cardiothorac Surg (2006) 1.30
Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation (2005) 1.13
A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg (2013) 1.06
Patient-prosthesis mismatch in patients with aortic stenosis undergoing isolated aortic valve replacement does not affect survival. Ann Thorac Surg (2010) 1.01
Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care (2014) 1.00
Titin isoform expression in aortic stenosis. Clin Sci (Lond) (2009) 0.94
Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation (2006) 0.93
Deep sternal wound infection requiring revision surgery: impact on mid-term survival following cardiac surgery. Eur J Cardiothorac Surg (2008) 0.93
Cerebral perfusion. Ann Thorac Surg (2007) 0.90
Mild renal dysfunction predicts in-hospital mortality and post-discharge survival following cardiac surgery. Eur J Cardiothorac Surg (2008) 0.88
Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target. Heart (2013) 0.87
The brain, the spinal cord, selective antegrade cerebral perfusion and corporeal arrest temperature - are we reducing the margin of patient safety in aortic arch surgery? Eur J Cardiothorac Surg (2009) 0.86
Donor cardiac troponin-I: a biochemical surrogate of heart function. Eur J Cardiothorac Surg (2009) 0.86
The fate of abstracts presented at annual meetings of the Society for Cardiothoracic Surgery in Great Britain and Ireland from 1993 to 2007. Eur J Cardiothorac Surg (2012) 0.84
Subtle changes in renal function are associated with differences in late survival following adult cardiac surgery. Eur J Cardiothorac Surg (2012) 0.83
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol (2002) 0.83
Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One (2011) 0.82
Glucose and insulin influences on heart and brain in cardiac surgery. Semin Cardiothorac Vasc Anesth (2005) 0.81
Prediction of in-hospital death following aortic valve replacement: a new accurate model. Eur J Cardiothorac Surg (2012) 0.79
How does glucose insulin potassium improve hemodynamic performance? Evidence for altered expression of beta-adrenoreceptor and calcium handling genes. Circulation (2006) 0.79
Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake. Br J Clin Pharmacol (2014) 0.79
The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function. Eur Heart J (2004) 0.78
A paradigm shift in aortic arch surgery, certainly--but corroboration required. Eur J Cardiothorac Surg (2012) 0.78
Aprotinin--still courting controversy. Lancet (2008) 0.78
Reduced negative surface charge on arterial endothelium explains accelerated atherosclerosis in type 2 diabetic patients. Diab Vasc Dis Res (2010) 0.77
Which troponometric best predicts midterm outcome after coronary artery bypass graft surgery? Ann Thorac Surg (2011) 0.76
Can we update the Summary Hospital Mortality Index (SHMI) to make a useful measure of the quality of hospital care? An observational study. BMJ Open (2013) 0.75
Reply to the editor. J Thorac Cardiovasc Surg (2013) 0.75
Editorial comment Redo proximal aortic surgery--lessons from Bologna. Eur J Cardiothorac Surg (2011) 0.75
MADCAP: a graphical method for assessing risk scoring systems. Eur J Cardiothorac Surg (2006) 0.75
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth (2017) 0.75